JANSSEN BIOTECH, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 108148
 
  
 
C07K PEPTIDES 9651
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7790
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1584
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 14192
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1386
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 9131
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 9145
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 913
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 544

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0044,427 Engineered Antibodies and Other FC-Domain Containing Molecules with Enhanced Agonism and Effector FunctionsJul 28, 17Feb 15, 18[C07K]
2018/0015,129 TREATMENT OF RETINAL VASCULAR DISEASE USING PROGENITOR CELLSJun 28, 17Jan 18, 18[A61K]
2017/0360,607 APPARATUS AND METHOD TO FORM ENTRY BLEB FOR SUBRETINAL DELIVERY OF THERAPEUTIC AGENTMay 31, 17Dec 21, 17[A61F, A61B, A61M]
2017/0362,572 GENERATION OF HUMAN PLURIPOTENT STEM CELL DERIVED FUNCTIONAL BETA CELLS SHOWING A GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSEJun 14, 17Dec 21, 17[A61K, C12Q, C12N, C07K]
2017/0327,793 DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLSAug 04, 17Nov 16, 17[A61K, C12N]
2017/0218,092 Bispecific Anti-TNF-Alpha/IL17A Antibodies and Anti-TNF-Alpha Antibodies and Methods of Their UseJan 27, 17Aug 03, 17[A61K, C07K]
2017/0183,626 DEFINED MEDIA FOR EXPANSION AND MAINTENANCE OF PLURIPOTENT STEM CELLSMar 13, 17Jun 29, 17[C12N]
2017/0183,630 DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLSMar 13, 17Jun 29, 17[C12N]
2017/0157,179 TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLSDec 01, 16Jun 08, 17[A61K]
2017/0080,033 TREATMENT OF RETINAL DEGENERATION USING PROGENITOR CELLSDec 01, 16Mar 23, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902770 Interferon alpha and omega antibody antagonistsMar 13, 14Feb 27, 18[A61K, C07K]
9897612 Fibronectin type III repeat based protein scaffolds with alternative binding surfacesAug 10, 15Feb 20, 18[C12N, G01N, C40B]
9889281 Cell encapsulation loading deviceFeb 18, 16Feb 13, 18[C12M, A61M]
9890353 Media suction devices and methodsMar 11, 14Feb 13, 18[C12M, G01N, B01D]
9862766 Method of treating lupus by administering an anti-IL-12 antibodyFeb 14, 17Jan 09, 18[A61K, C12Q, C07K]
9845460 Treatment of pluripotent cellsNov 20, 13Dec 19, 17[A61K, C12N]
9828424 Anti-TNF antibodies, compositions, methods and usesMar 21, 16Nov 28, 17[A61K, G01N, C07K]
9783607 Human anti-IL-23 antibodies, compositions, methods and usesApr 29, 16Oct 10, 17[A61K, C07K]
9752125 Differentiation of human embryonic stem cellsMay 11, 11Sep 05, 17[C12N]
9752126 Differentiation of human pluripotent stem cellsDec 09, 15Sep 05, 17[C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0121,409 ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USESAbandonedNov 01, 16May 04, 17[A61K, C07K]
2016/0257,726 PROTOXIN-II VARIANTS AND METHODS OF USEAbandonedMar 03, 16Sep 08, 16[C07K]
2016/0222,106 Anti-CD38 Antibodies for Treatment of Acute Myeloid LeukemiaAbandonedDec 02, 15Aug 04, 16[A61K, A61N, C07K]
2016/0067,205 Combination Therapies with Anti-CD38 AntibodiesAbandonedSep 08, 15Mar 10, 16[A61K, C07K]
2015/0087,812 Human Autotaxin Antibodies and Methods of UseAbandonedMar 11, 13Mar 26, 15[C07K]
2014/0273,092 MANUFACTURING METHODS TO CONTROL C-TERMINAL LYSINE, GALACTOSE AND SIALIC ACID CONTENT IN RECOMBINANT PROTEINSAbandonedMar 13, 14Sep 18, 14[C07K]
2014/0212,413 Methods of Treating TNF-alpha-Mediated Diseases Using Chimeric TNF-alpha AntibodiesAbandonedJan 17, 14Jul 31, 14[A61K, C07K]
2014/0141,013 ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USESAbandonedJan 29, 14May 22, 14[C07K]
2014/0141,459 PENTRAXIN 3 ASSOCIATION WITH ASTHMAAbandonedJul 27, 12May 22, 14[G01N]
2014/0093,523 Anti-Integrin Immunoconjugates, Methods and UsesAbandonedDec 04, 13Apr 03, 14[A61K]
2014/0079,711 ANTI-CD147 ANTIBODIES, METHODS AND USESAbandonedNov 19, 13Mar 20, 14[C07K]
2014/0050,745 Melanocortin Receptor Binding ConjugatesAbandonedOct 23, 13Feb 20, 14[A61K]
2014/0017,250 Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular DiseasesAbandonedMay 06, 13Jan 16, 14[C07K]
8629106 Affinity peptides toward BMP-2ExpiredMar 10, 11Jan 14, 14[A61K, C07K]
2014/0011,704 Markers and Methods for Assessing and Treating Crohn's Disease and Related DisordersAbandonedSep 18, 13Jan 09, 14[C12Q]
2014/0011,879 SERUM MARKERS FOR IDENTIFICATION OF CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTSAbandonedSep 27, 11Jan 09, 14[G01N, G06F]
8618264 Anti-CD147 antibodies, methods and usesExpiredAug 19, 09Dec 31, 13[C07K]
8614185 Fusion proteins of alpha-MSH derivatives and FcExpiredApr 27, 10Dec 24, 13[A61K]
2013/0337,564 Treatment of Pluripotent CellsAbandonedJun 13, 13Dec 19, 13[C12N]
8603483 Anti-integrin immunoconjugates, methods and usesExpiredNov 30, 05Dec 10, 13[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.